MedTrace Logo

Ziprasidone and Sertraline in PTSD

NCT00248261 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2020-02-25

No results posted yet for this study

Summary

Serotonin re-uptake inhibitors, such as sertraline, are the medication of choice in post-traumatic stress disorder. However, it takes several weeks before they ameliorate symptoms. Therefore, we will add ziprasidone (vs. placebo) medication during the first four weeks of sertraline in order to find out if this strategy accelerates symptomatic relief.

Conditions

  • Post-traumatic Stress Disorder

Interventions

DRUG

ziprasidone, sertraline

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Michael B Kellner, MD, PhD · UKE, Dep. of Pschiatry and Psychotherapy, Hamburg, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2009-08-31
Completion
2010-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00248261 on ClinicalTrials.gov